» Articles » PMID: 29808701

Oral Microbiome in HIV-Infected Women: Shifts in the Abundance of Pathogenic and Beneficial Bacteria Are Associated with Aging, HIV Load, CD4 Count, and Antiretroviral Therapy

Overview
Publisher Mary Ann Liebert
Date 2018 May 30
PMID 29808701
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Human immunodeficiency virus (HIV)-associated nonacquired immunodeficiency syndrome (AIDS) conditions, such as cardiovascular disease, diabetes, osteoporosis, and dementia are more prevalent in older than in young adult HIV-infected subjects. Although the oral microbiome has been studied as a window into pathogenesis in aging populations, its relationship to HIV disease progression, opportunistic infections, and HIV-associated non-AIDS conditions is not well understood. We utilized 16S rDNA-based pyrosequencing to compare the salivary microbiome in three groups: (1) Chronically HIV-infected women >50 years of age (aging); (2) HIV-infected women <35 years of age (young adult); and (3) HIV-uninfected age-matched women. We also examined correlations between salivary dysbiosis, plasma HIV RNA, CD4 T cell depletion, and opportunistic oral infections. In both aging and young adult women, HIV infection was associated with salivary dysbiosis characterized by increased abundance of Prevotella melaninogenica and Rothia mucilaginosa. Aging was associated with increased bacterial diversity in both uninfected and HIV-infected women. In HIV-infected women with oral coinfections, aging was also associated with reduced abundance of the common commensal Veillonella parvula. Patients taking antiretroviral therapy showed increased numbers of Neisseria and Haemophilus. High plasma HIV RNA levels correlated positively with the presence of Prevotella and Veillonella, and negatively with the abundance of potentially beneficial Streptococcus and Lactobacillus. Circulating CD4 T cell numbers correlated positively with the abundance of Streptococcus and Lactobacillus. Our findings extend previous studies of the role of the microbiome in HIV pathogenesis, providing new evidence that HIV infection is associated with a shift toward an increased pathogenic footprint of the salivary microbiome. Taken together, the data suggest a complex relationship, worthy of additional study, between chronic dysbiosis in the oral cavity, aging, viral burden, CD4 T cell depletion, and long-term antiretroviral therapy.

Citing Articles

Microbiome analysis in individuals with human papillomavirus oral infection.

Escobar Marcillo D, Privitera G, Rollo F, Latini A, Giuliani E, Benevolo M Sci Rep. 2025; 15(1):2953.

PMID: 39848958 PMC: 11757712. DOI: 10.1038/s41598-024-81607-4.


Microbiota of Saliva: A Non-invasive Diagnostic Tool.

Shinde D, Mahore J, Giram P, Singh S, Sharda A, Choyan D Indian J Microbiol. 2024; 64(2):328-342.

PMID: 39010986 PMC: 11246313. DOI: 10.1007/s12088-024-01219-4.


Human immunodeficiency virus and oral microbiota: mutual influence on the establishment of a viral gingival reservoir in individuals under antiretroviral therapy.

Ramos Pena D, Pillet S, Lourenco A, Pozzetto B, Bourlet T, Motta A Front Cell Infect Microbiol. 2024; 14:1364002.

PMID: 38660490 PMC: 11039817. DOI: 10.3389/fcimb.2024.1364002.


Traditional Chinese medicine (Xielikang) reduces diarrhea symptoms in acquired immune deficiency syndrome (AIDS) patients by regulating the intestinal microbiota.

Meng P, Zhang G, Ma X, Ding X, Song X, Dang S Front Microbiol. 2024; 15:1346955.

PMID: 38435694 PMC: 10904582. DOI: 10.3389/fmicb.2024.1346955.


Microbiota in the oral cavity of school-age children with HIV who started antiretroviral therapy at young ages in South Africa.

Kuhn L, Wang T, Li F, Strehlau R, Tobin N, Violari A AIDS. 2023; 37(10):1583-1591.

PMID: 37199568 PMC: 10524539. DOI: 10.1097/QAD.0000000000003599.


References
1.
Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S . Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol. 1998; 37(1):132-6. PMC: 84187. DOI: 10.1128/JCM.37.1.132-136.1999. View

2.
Cheung M, Lam W, Fung W, Law P, Au C, Nong W . Sputum microbiota in tuberculosis as revealed by 16S rRNA pyrosequencing. PLoS One. 2013; 8(1):e54574. PMC: 3554703. DOI: 10.1371/journal.pone.0054574. View

3.
Clark U, Cohen R . Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals. Curr Opin Investig Drugs. 2010; 11(8):884-900. PMC: 4021717. View

4.
Dubrow R, Silverberg M, Park L, Crothers K, Justice A . HIV infection, aging, and immune function: implications for cancer risk and prevention. Curr Opin Oncol. 2012; 24(5):506-16. PMC: 3695478. DOI: 10.1097/CCO.0b013e328355e131. View

5.
Ofotokun I, Mcintosh E, Weitzmann M . HIV: inflammation and bone. Curr HIV/AIDS Rep. 2011; 9(1):16-25. PMC: 3286635. DOI: 10.1007/s11904-011-0099-z. View